This article is more than 5 years old. Information may no longer be current.

FDA approves AcrySof IQ ReSTOR +3.0 D multifocal toric IOL

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The FDA has approved Alcon’s AcrySof IQ ReSTOR +3.0 D multifocal toric IOL, according to a company press release.

The lens is designed for the treatment of both presbyopia and corneal astigmatism in adult patients at the time of cataract surgery, the release said. It is already available in the European Union, Australia, Canada, and multiple countries throughout Central and South America and Asia.

Commercial rollout will begin in the U.S. in the first quarter of 2017, according to the release.